Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer
ClinicalTrials.gov study NCT01145404. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer
ClinicalTrials.gov study NCT01537536. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT00705315. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
ClinicalTrials.gov study NCT03685331. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
ClinicalTrials.gov study NCT05681780. IPD Sharing: NO. Countries: 1. Publications: 1.
Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions
ClinicalTrials.gov study NCT04382300. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT03532087. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
ClinicalTrials.gov study NCT06048718. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02448420. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
ClinicalTrials.gov study NCT04172259. IPD Sharing: UNDECIDED. Countries: 1. Publications: 20.
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
ClinicalTrials.gov study NCT03716180. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03084939. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
ClinicalTrials.gov study NCT04886804. IPD Sharing: NO. Countries: 18. Publications: 3.
Eribulin in Brain Metastases From HER2-negative Breast Cancer
ClinicalTrials.gov study NCT03637868. IPD Sharing: NO. Countries: 1. Publications: 19.
A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
ClinicalTrials.gov study NCT04513223. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer
ClinicalTrials.gov study NCT01983501. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
ClinicalTrials.gov study NCT03876587. IPD Sharing: YES. Countries: 1. Publications: 2.
Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients
ClinicalTrials.gov study NCT05203458. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT02396108. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT03691051. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.